Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Alison Bryant (email | Twitter) and Nesa Nourmohammadi (email | Twitter) and we will feature it here each Friday.
Innovative Pulmonary Solutions lands new CEO
Innovative Pulmonary Solutions, a Bellevue, WA-based startup, welcomed medical device veteran Dennis Wahr as chief executive officer. Prior to coming aboard, Wahr helmed devicemaker Lutonix before it was bought by C.R. Bard ($BCR) in 2011, and co-founded Velocimed, which was eventually snapped up by St. Jude Medical ($STJ). "We looked very diligently to find the right executive to carry IPS to the next level as we continue on our development pathway," company co-founder Steve Dimmer said. "With his wealth of operations and clinical stage experience, we're excited to have Dennis at the helm and look forward to our new corporate headquarters in Minneapolis." Story | Release
|
Dennis Wahr--Innovative Pulmonary Solutions
Brian Kelly--Quintiles
Biotech
> Rajiv De Silva, Valeant Pharmaceuticals' ($VRX) president and chief operating officer of specialty pharmaceuticals, will leave the company at the end of the year to pursue other interests. News
> Dr. Brian Kelly joined CRO Quintiles as its new president of payer and provider solutions. Release
> Mucosis, a Dutch clinical-stage biotech company developing mucosal vaccines, announced the appointment of Thomas Johnston to the position of chief executive officer, effective immediately. Release
> Northwest Biotherapeutics appointed former pharmaceutical executive Günter Rosskamp as CEO of the company's German subsidiary, Northwest Biotherapeutics, Gmbh. Release
> Cenduit appointed John Cline as vice president of client services. He joins the company from ArisGlobal, where he was vice president of global field operations. Release
> Marceline Clementine was appointed chief financial officer at French biotech Trophos SA. Release
> Emisphere Technologies announced the appointment of Alan Rubino to the position of president and CEO, effective immediately. Release
> Igenica appointed Mary Haak-Frendscho as CEO. Release
> Cook Pharmica named Victor Vinci as vice president and chief scientific officer. Release
Medical Devices
> AdvaMed announced that John Graham has been named vice president of payment and healthcare delivery research and policy. Release
> Brian Hess was appointed as interim chief science officer at InVivo Therapeutics. He fills the spot vacated by Dr. Edward Wirth, who left InVivo for personal reasons, according to the company. Release